AI-Based 3D Myocardial Blood Flow Mapping with 82Rb PET

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods for generating three-dimensional (3D) parametric maps of myocardial blood flow (MBF) are time-consuming, unstable, particularly in areas of high arterial blood concentration, and fail to accurately identify small regional flow defects, discouraging their use in clinical settings.

Innovation Solution

An AI-based, unsupervised neural network model is used to automate the process of generating 3D parametric maps, optimizing arterial input function (AIF) selection and reducing the need for manual intervention, thereby improving the accuracy and speed of MBF and myocardial flow reserve (MFR) estimation.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If traditional methods are used to generate 3D parametric maps of MBF, then measurement precision can be achieved, but the process is time-consuming and unstable

Engineering Contradiction:
ImproveMBF measurement precisionVSAvoidTime consumption
Core Design Contradiction:
Measurement precisionVSLoss of time

Solution Approach 1:

The patent replaces traditional mechanical/computational methods with AI-based deep learning models (U-Net architecture) to automate the generation of 3D parametric maps. The neural network learns to directly map PET images to MBF parameter maps, eliminating the need for time-consuming manual segmentation and kinetic modeling while achieving comparable or superior precision.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent uses AI models to create digital copies of the complex physiological processes. The deep learning model learns from training data the relationship between PET images and MBF parameters, then replicates this relationship to generate accurate 3D parametric maps rapidly without repeating the complex computational steps of traditional methods.

Inventive Principle:
Principle #26Copying

2Measurement precision

If traditional methods are used to generate 3D parametric maps, then measurement precision can be achieved, but stability deteriorates particularly in areas of high arterial blood concentration

Engineering Contradiction:
ImproveMBF measurement precisionVSAvoidMap stability
Core Design Contradiction:
Measurement precisionVSReliability

Solution Approach 1:

The patent replaces traditional computational methods with AI-based deep learning models (U-Net architecture) to automate the generation of 3D parametric maps. The neural network learns to directly map PET images to MBF parameter maps, eliminating the need for time-consuming manual segmentation and kinetic modeling while achieving comparable or superior precision.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent incorporates feedback mechanisms through the training process, where the model continuously refines its ability to accurately segment myocardium and calculate MBF parameters. The training data includes ground truth labels that provide feedback on accuracy, enabling the model to learn from errors and improve stability in challenging regions like high arterial blood concentration areas.

Inventive Principle:
Principle #23Feedback

3Measurement precision

If traditional methods are used for MBF estimation, then measurement precision can be achieved, but the ability to identify small regional flow defects deteriorates

Engineering Contradiction:
ImproveMBF measurement precisionVSAvoidSmall regional flow defect detection
Core Design Contradiction:
Measurement precisionVSDifficulty of detecting and measuring

Solution Approach 1:

The patent employs sophisticated segmentation techniques through the U-Net architecture that divides the 3D myocardium into numerous small volumetric elements (voxels). This fine-grained segmentation allows the model to detect and quantify small regional flow defects that would be invisible in coarser traditional methods, while maintaining overall measurement precision through the integrated kinetic modeling.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent transitions from traditional 2D polar map representations to 3D volumetric parametric maps. This dimensional change enables the visualization and detection of small regional flow defects in three-dimensional space, providing superior spatial resolution and the ability to identify subtle perfusion abnormalities that are lost in two-dimensional projections.

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

4Productivity

If AI-based methods are used to generate 3D parametric maps, then speed and accuracy are improved, but device complexity increases

Engineering Contradiction:
ImproveMBF estimation speedVSAvoidSystem complexity
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The patent performs preliminary action by training the AI model offline using extensive training data and computational resources. Once trained, the model weights are fixed and can be applied to new patients rapidly without requiring complex real-time computations. This preliminary training phase captures the complexity of the task, allowing for fast inference during actual clinical use.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent uses AI models to create digital copies of the complex physiological processes. The deep learning model learns from training data the relationship between PET images and MBF parameters, then replicates this relationship to generate accurate 3D parametric maps rapidly without repeating the complex computational steps of traditional methods.

Inventive Principle:
Principle #26Copying

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The AI-driven method enables rapid, accurate estimation of MBF and MFR, highlighting small regional flow defects and providing stable, high-quality 3D images, reducing the dose of nuclear medicine by up to 10 times and enabling clinical implementation.

Implementation Method 1

82Rb is produced in-situ by radioactive decay of 82Sr (Strontium-82)

Methodology Applied
Scientific EffectRadioactive decay: Radioactive Decay

Implementation Method 2

the radiopharmaceuticals can be absorbed by the cells or adhered to the cells of a target organ of the patient and emit radiation. The scanner or detector of the diagnostic imaging process can then detect the emitted radiation

Methodology Applied
Scientific EffectRadiation emission: Radiation

Implementation Method 3

An AI-based, unsupervised neural network model is used to automate the process of generating 3D parametric maps, optimizing arterial input function (AIF) selection and reducing the need for manual intervention

Methodology Applied
Scientific EffectArtificial intelligence processing:

Implementation Method 4

the radiopharmaceuticals can be absorbed by the cells or adhered to the cells of a target organ of the patient

Methodology Applied
Scientific EffectAbsorption: Absorption (physical)

Data Source

PatentUS20250315952A1Artificial intelligence-based tool for myocardial blood flow parametric mapping to diagnose coronary artery disease with 82rb positron emission tomography
Publication Date: 2025.10.09 JUBILANT DRAXIMAGE INC
  • US20250315952A1 patent drawing
  • US20250315952A1 patent drawing
  • US20250315952A1 patent drawing

AI summary

The present invention discloses methods for automatically computing an arterial input function from one or more regions of interest, the method comprising: a. obtaining a plurality of dynamic image data sets comprising volumetric image data from the regions of interest over multiple scanning intervals; b. utilizing an artificial neural network to segment the plurality of dynamic image data sets displaying one or more arterial input function(s) (AIF) in the region(s) of interest; c. automatically estimating, using artificial intelligence, an arterial input function based on plurality of dynamic image data sets combined with one or more time activity curves (TAC) in the region(s) of interest in target organ(s); and d. computing a pre-trained predictive pharmacokinetic AI model arterial input function using time activity curve input associated with region(s) of interest of target organ(s).